Endomyocardial biopsy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
An endomyocardial biopsy is an invasive heart procedure that is performed to obtain a small piece of myocardial tissue for pathologic evaluation.
An endomyocardial biopsy is an invasive heart procedure that is performed to obtain a small piece of myocardial tissue for pathologic evaluation.


==Disease States that can be Diagnosed Using Endomyocardial Biopsy==
==Disease States that can be Diagnosed Using Endomyocardial Biopsy==
Line 15: Line 13:


==The Biopsy Procedure==
==The Biopsy Procedure==
The procedure can be performed either from the neck (using the [[jugular vein]]), or from the femoral vein.
The procedure can be performed either from the neck (using the [[jugular vein]]), or from the femoral vein.
===Approach from the neck===
===Approach from the neck===
Line 50: Line 47:
*[[Pneumothorax]]
*[[Pneumothorax]]


{{SIB}}
[[Category:Cardiology]]
[[Category:Cardiology]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 21:35, 4 September 2011

WikiDoc Resources for Endomyocardial biopsy

Articles

Most recent articles on Endomyocardial biopsy

Most cited articles on Endomyocardial biopsy

Review articles on Endomyocardial biopsy

Articles on Endomyocardial biopsy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Endomyocardial biopsy

Images of Endomyocardial biopsy

Photos of Endomyocardial biopsy

Podcasts & MP3s on Endomyocardial biopsy

Videos on Endomyocardial biopsy

Evidence Based Medicine

Cochrane Collaboration on Endomyocardial biopsy

Bandolier on Endomyocardial biopsy

TRIP on Endomyocardial biopsy

Clinical Trials

Ongoing Trials on Endomyocardial biopsy at Clinical Trials.gov

Trial results on Endomyocardial biopsy

Clinical Trials on Endomyocardial biopsy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Endomyocardial biopsy

NICE Guidance on Endomyocardial biopsy

NHS PRODIGY Guidance

FDA on Endomyocardial biopsy

CDC on Endomyocardial biopsy

Books

Books on Endomyocardial biopsy

News

Endomyocardial biopsy in the news

Be alerted to news on Endomyocardial biopsy

News trends on Endomyocardial biopsy

Commentary

Blogs on Endomyocardial biopsy

Definitions

Definitions of Endomyocardial biopsy

Patient Resources / Community

Patient resources on Endomyocardial biopsy

Discussion groups on Endomyocardial biopsy

Patient Handouts on Endomyocardial biopsy

Directions to Hospitals Treating Endomyocardial biopsy

Risk calculators and risk factors for Endomyocardial biopsy

Healthcare Provider Resources

Symptoms of Endomyocardial biopsy

Causes & Risk Factors for Endomyocardial biopsy

Diagnostic studies for Endomyocardial biopsy

Treatment of Endomyocardial biopsy

Continuing Medical Education (CME)

CME Programs on Endomyocardial biopsy

International

Endomyocardial biopsy en Espanol

Endomyocardial biopsy en Francais

Business

Endomyocardial biopsy in the Marketplace

Patents on Endomyocardial biopsy

Experimental / Informatics

List of terms related to Endomyocardial biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

An endomyocardial biopsy is an invasive heart procedure that is performed to obtain a small piece of myocardial tissue for pathologic evaluation.

Disease States that can be Diagnosed Using Endomyocardial Biopsy

The Biopsy Procedure

The procedure can be performed either from the neck (using the jugular vein), or from the femoral vein.

Approach from the neck

  • Jugular vein approach (especially right internal jugular vein). Endomyocardial biopsy is performed in a supine position with local anesthesia.
  • Subclavian vein approach is not preferable for a variety of reasons as: local anesthesia is less effective, because of the clavicle, the risk of pneumothorax is significantly higher as compared to puncture of the internal jugular vein and due to the anatomical course of the great veins, direction of the bioptome is more difficult.

Approach from the femoral vein

Evaluation of Biopsy Specimen

Biopsy specimens are prepared for light microscopy by hematoxiline – eosine staining.

Grading of Rejection

Morphologically, acute rejection is a mononuclear inflammatory reaction of predominantly lymphocytes against the myocardium. Grading of rejection is performed according to the guidelines of the International Society for Heart and Lung Transplantation (ISHLT) as follows:

  • Grade 0: no evidence of rejection
  • Grade Ia: focal perivascular or interstitial infiltrate without myocardial injury
  • Grade Ib: multifocal or diffuse sparse infiltrate without myocardial injury
  • Grade II: single focus or dense infiltrate with myocyte injury
  • Grade IIIa: multifocal dense infiltrates with myocyte injury
  • Grade IIIb: diffuse, dense infiltrates with myocyte injury
  • Grade IV: diffuse and extensive polymorphous infiltrate with myocyte injury; may have hemorrhage, edema, and microvascular injury

Categories of cellular rejection

  • Grade 0 R: no rejection
  • Grade 1 R: mild rejection (Grades I A, I B and II)
  • Grade 2 R: moderate rejection (Grade III A)
  • Grade 3 R: severe rejection (Grade III B and IV)

Complications

Template:WikiDoc Sources